BACKGROUND: Clozapine is uniquely effective in treatment-resistant psychosis but remains underutilised, partly owing to psychotic symptoms leading to non-adherence to oral medication. An intramuscular formulation is available in the UK but outcomes remain unexplored.AIMS: This was a retrospective clinical effectiveness study of intramuscular clozapine prescription for treatment initiation and maintenance in treatment-resistant psychosis over a 3-year period.METHOD: Successful initiation of oral clozapine after intramuscular prescription was the primary outcome. Secondary outcomes included all-cause clozapine discontinuation 2 years following initiation, and 1 year after discharge. Discontinuation rates were compared with a cohort prescribed...
A retrospective cohort study, with a mirror-image design, was used to measure inpatient service util...
BACKGROUND: Clozapine is the only antipsychotic drug licensed for treatment-resistant schizophrenia ...
Although clozapine treatment is often discontinued due to limited efficacy or low tolerability, ther...
Background Clozapine is uniquely effective in treatment-resistant psychosis but remains underutilise...
Aims and method: A series of eleven patients prescribed intramuscular clozapine at five UK sites is ...
Treatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based ph...
Background: Clozapine is the gold standard in treatment of treatment-resistant psychotic patients. W...
Objective: To document and measure various parameters and outcomes in patients prescribed clozapine ...
Background: Clozapine is the gold standard in treatment of treatment-resistant psychotic patients. W...
Aim: It is reported that clozapine maintenance treatment could be effective in treatment-resistant b...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Objectives: A quarter of people with schizophrenia may be classed as 'treatment-resistant'. Clozapin...
There is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs ...
Clozapine is seldom prescribed in treatment-resistant schizophrenia (TRS) patients during early phas...
A retrospective cohort study, with a mirror-image design, was used to measure inpatient service util...
BACKGROUND: Clozapine is the only antipsychotic drug licensed for treatment-resistant schizophrenia ...
Although clozapine treatment is often discontinued due to limited efficacy or low tolerability, ther...
Background Clozapine is uniquely effective in treatment-resistant psychosis but remains underutilise...
Aims and method: A series of eleven patients prescribed intramuscular clozapine at five UK sites is ...
Treatment resistance causes significant burden in psychosis. Clozapine is the only evidence-based ph...
Background: Clozapine is the gold standard in treatment of treatment-resistant psychotic patients. W...
Objective: To document and measure various parameters and outcomes in patients prescribed clozapine ...
Background: Clozapine is the gold standard in treatment of treatment-resistant psychotic patients. W...
Aim: It is reported that clozapine maintenance treatment could be effective in treatment-resistant b...
To access publisher's full text version of this article, please click on the hyperlink in Additional...
Objectives: A quarter of people with schizophrenia may be classed as 'treatment-resistant'. Clozapin...
There is good evidence that clozapine is more efficacious than first-generation antipsychotic drugs ...
Clozapine is seldom prescribed in treatment-resistant schizophrenia (TRS) patients during early phas...
A retrospective cohort study, with a mirror-image design, was used to measure inpatient service util...
BACKGROUND: Clozapine is the only antipsychotic drug licensed for treatment-resistant schizophrenia ...
Although clozapine treatment is often discontinued due to limited efficacy or low tolerability, ther...